Drug profile

The FDA adverse-event record for Anti-Anxiety Medication (Unknown)

40 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Anti-Anxiety Medication (Unknown). See the species affected, top reactions, and outcomes below.

40
adverse-event reports
2.5%
death-coded share
Dog
most-reported species
7
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
40
Total Reports
1
Deaths Reported
2.5%
Death Rate

Active Ingredients

Anti-Anxiety Medication (Unknown)

Administration Routes

UnknownOralTopical

Species Affected

Dog 34
Human 4
Cat 2

Most Affected Breeds

Unknown 4
Chihuahua 4
Spitz - German Pomeranian 3
Retriever - Labrador 3
Shepherd Dog - German 2
Shepherd (unspecified) 2
Greyhound 2
Crossbred Canine/dog 2
Alaskan Malamute 1
Retriever (unspecified) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 7
Emesis 6
Vomiting 6
Diarrhoea 5
Lack of efficacy - NOS 3
Anorexia 3
Anxiety 3
Lack of efficacy (ectoparasite) - flea 2
Panting 2
Dilated pupils 2
Accidental exposure 2
Digestive tract disorder NOS 2

Outcome Breakdown

Recovered/Normal
22 (55.0%)
Outcome Unknown
10 (25.0%)
Ongoing
7 (17.5%)
Euthanized
1 (2.5%)

Anti-Anxiety Medication (Unknown) Adverse Event Insights

40 reports name Anti-Anxiety Medication (Unknown); 1 recorded a death outcome (2.5% of reported events, not a population-level mortality rate). Active ingredient: Anti-Anxiety Medication (Unknown). Administration routes: Unknown, Oral, Topical.

By species: Dog (34 reports), Human (4 reports), Cat (2 reports). By breed: Unknown (4), Chihuahua (4), Spitz - German Pomeranian (3).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (7), Emesis (6), Vomiting (6), Diarrhoea (5). Outcome, 40 coded reports: Recovered/Normal leads at 55.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.